• No results found

Molecular Diagnostics of Uncommon Soft Tissue and Bone Tumors

N/A
N/A
Protected

Academic year: 2021

Share "Molecular Diagnostics of Uncommon Soft Tissue and Bone Tumors"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Molecular Diagnostics of Uncommon Soft Tissue and Bone Tumors Song, Wangzhao

DOI:

10.33612/diss.127007579

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2020

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Song, W. (2020). Molecular Diagnostics of Uncommon Soft Tissue and Bone Tumors. University of Groningen. https://doi.org/10.33612/diss.127007579

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Propositions accompanying the dissertation

Molecular Diagnostics of Uncommon

Soft Tissue and Bone Tumors

Wangzhao Song

1. CellientTM automated cell block technique has great potential for the

cytological diagnosis of soft tissue and bone tumors (this thesis).

2. NanoString FusionPlex assay is a rapid, cost-effective, sensitive, and specific ancillary screening tool for molecular diagnosis of five soft tissue tumor types (this thesis).

3. Myoepithelial tumors of bone illustrate the challenge pathologists face in daily diagnostic work (this thesis).

4. PHF1-TFE3 fusions occur in a subset of ossifying fibromyxoid tumors with aggressive clinical behavior (this thesis).

5. Soft tissue aneurysmal bone cysts belong to a spectrum of tumors with USP6 gene rearrangements (this thesis).

6. Molecular analysis may contribute in discriminating low-grade central fibroblastic osteosarcoma from desmoplastic fibroma (this thesis).

7. Recognizing soft tissue tumors associated with NTRK and other kinase related fusions opens new avenues for targeted therapy.

8. Dreams are worth dreaming, as even an impossible one might come true. 9. Some things force you to grow overnight; some people make you grateful all

Referenties

GERELATEERDE DOCUMENTEN

Chapter 5 Soft tissue tumors: value of static and dynamic 59 Gd-DTPA-enhanced MR imaging in predicting malignancy. Chapter 6 Diffusion-weighted MR imaging in the characterization of

The purpose of this thesis is to explore and evaluate new and optimized MR imaging techniques, including fast dynamic contrast-enhanced MR imaging and diffusion- weighted MR imaging,

However, only one case exhibited all three dynamic contrast-enhanced MR features associated with malignancy, i.e., early start of tumor enhancement, peripheral tumoral enhancement

By combining dynamic contrast-enhanced MR characteristics with morphologic findings, we could differentiate, to some extent, the various peripheral vascular malformations (Table

The incremental value of static contrast-enhanced MR parameters and a combination of static and dynamic contrast-enhanced MR parameters relative to the value of nonenhanced MR

Measurement of signal attenuation at different diffusion-sensitizing gradient strengths allows estimation of true diffusion coefficients and the perfusion fraction (1;10;11),

Patient characteristics MR imaging findings Histopathological examination Tumor Standard Areas of early Pattern of early Progression of No Gender, Location volume nonenhanced

In chapter 5, the usefulness of static and dynamic contrast-enhanced MR imaging, relative to nonenhanced MR imaging, in differentiating benign from malignant soft tissue lesions